- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne - - Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 ...

The right treatment for the right patient is key to treating acne safely. Acne is a chronic disease of the pilosebaceous follicle that causes polymorph cutaneous lesions, among them comedones ...

Evaluation of patients with acne should be made at intervals of 3 to 12 weeks, with more frequent consultations in the initial phase of the treatment. A topical maintenance therapy should be the ...

However, like typical acne, maintaining good hygiene may not be enough to treat your scalp pimples. Luckily, there are multiple treatment options you can try. Over-the-Counter (OTC) medicated ...

I am very pleased for clinicians and patients across the UK that our three organisations have worked together to produce a guideline that will impact on diagnosis and treatment of patients with asthma ...

said the clinical trial will help to generate valuable data on the disease and its treatment. “The translational study will explore the role of skin bacteria and biological responses in acne ...